Rekor Systems (NasdaqCM:REKR) Q4 2025 Earnings call March 31, 2026 04:30 PM ET Company ParticipantsJoseph Nalepa - CFORobert A. Berman - Chairman and CEOConference Call ParticipantsLouie DiPalma - AnalystMichael Latimore - Managing Director and Senior Research AnalystOperatorGood afternoon, ladies and gentlemen, and welcome to today's Rekor Systems, Inc. conference call. My name is Kevin and I'll be your coordinator for today. At this time, all participants are in listen-only mode. If anyone should require ...

TOMI Environmental Solutions (NasdaqCM:TOMZ) Q4 2025 Earnings call March 31, 2026 04:30 PM ET Company ParticipantsDavid Vanston - CFOEJ Shane - COOHalden Shane - CEO and ChairmanZach Nevas - Account ExecutiveConference Call ParticipantsCarl Wright - AnalystJohn Nelson - AnalystOperatorGood day, and welcome to the TOMI Environmental Solutions, Inc. 2025 financial results conference call. At this time, all participants have been placed on a listen-only mode. The floor will be open for questions and comments f ...

Barfresh Food Group (NasdaqCM:BRFH) Q4 2025 Earnings call March 31, 2026 04:30 PM ET Company ParticipantsLisa Roger - CFORiccardo Delle Coste - Founder and CEOConference Call ParticipantsAnkur Sagar - AnalystThomas McGovern - AnalystOperatorGood afternoon, everyone, and thank you for participating on today's fourth quarter and full year 2025 earnings conference call and webcast for Barfresh Food Group. Joining us today is Barfresh Food Group's Founder and CEO, Riccardo Delle Coste, and Barfresh Food Group's ...

Workhorse Group (NasdaqCM:WKHS) Q4 2025 Earnings call March 31, 2026 04:30 PM ET Company ParticipantsBob Ginnan - CFOJohn Williams - Chief Communications OfficerScott Griffith - CEOConference Call ParticipantsBen Somers - AnalystCraig Irwin - Managing Director, Senior Research AnalystMichael Shlisky - Managing Director, Senior Research AnalystOperatorPlease note this conference is being recorded. I will now turn the conference over to John Williams, Chief Communications Officer. Thank you. You may begin.Joh ...

Workhorse Group (NasdaqCM:WKHS) Q4 2025 Earnings call March 31, 2026 04:30 PM ET Company ParticipantsBob Ginnan - CFOJohn Williams - Chief Communications OfficerScott Griffith - CEOConference Call ParticipantsBen Somers - AnalystCraig Irwin - Managing Director, Senior Research AnalystMichael Shlisky - Managing Director, Senior Research AnalystOperatorPlease note this conference is being recorded. I will now turn the conference over to John Williams, Chief Communications Officer. Thank you. You may begin.Joh ...

Financial Data and Key Metrics Changes - Fourth quarter revenues increased by 25% year-over-year to $9.1 million, within management guidance [8][11] - Full year revenues reached $34.5 million, up 37% from the previous year [9] - Gross margins for the fourth quarter were 58%, up 100 basis points year-over-year, and 59% for the full year, up 400 basis points [9][12] - Net losses for the fourth quarter totaled $2.2 million, improving from a net loss of $3 million in the same period last year [12][13] - Cash and cash equivalents as of December 31, 2025, were $23 million, compared to $2.4 million a year earlier [13] Business Line Data and Key Metrics Changes - The direct-to-consumer (D2C) products division, led by the VINIA platform, is expected to achieve profitability in 2026 [8] - The D2C business generated full year revenues of $30.6 million, making it the number one resveratrol polyphenol brand in the U.S. [15][16] - The CDMO business generated approximately $2 million in third-party revenue in 2025, with total activity reaching about $9 million when including internal manufacturing [28][29] Market Data and Key Metrics Changes - The VINIA brand has over 85,000 active users, with a significant portion of revenue coming from subscription sales [11][14] - VINIA Blood Flow Hydration has achieved a verified rating of 4.8 out of 5 on vinia.com and 4.9 out of 5 on Amazon, indicating strong market acceptance [19][20] Company Strategy and Development Direction - The company operates through two distinct business units: D2C products and CDMO services, which are seen as dual growth engines [6][8] - The company plans to leverage its VINIA Blood Flow Hydration product to broaden its customer base and appeal to younger demographics [21][22] - The company is focusing on premiumization strategies and exploring new product categories, including VINIA Plus opportunities in multi-billion-dollar markets [26][27] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to accelerate growth and create long-term value through its two-lens model [39] - The ongoing conflict in the Middle East has raised concerns, but operations remain uninterrupted, and supply chain obligations are being met [9] - Management anticipates nonlinear revenue growth in 2026, with Q1 expected to show moderate growth before accelerating in subsequent quarters [72] Other Important Information - The company is investing in improvements to CDMO capabilities, including AI-driven development tools [36] - The CDMO division is evolving from a traditional service model to a partner development and manufacturing organization, allowing for long-term value creation [34] Q&A Session Summary Question: Details on the CDMO business and Tate & Lyle contract expectations - Management highlighted significant progress in the CDMO business and emphasized the importance of structuring the organization for resource allocation [41][42] Question: Pipeline expectations for CDMO - Management confirmed ongoing investments in infrastructure to support multiple projects and expects to double or triple revenue from external customers in 2026 [59][60] Question: Marketing shifts for VINIA and expected effects - Management noted that the Blood Flow Hydration product is appealing to various consumer segments and is optimistic about the marketing mix adjustments [64][66] Question: Revenue phasing expectations for 2026 - Management indicated that Q1 will show moderate growth, with acceleration expected in Q2 and beyond due to incremental investments [72][73] Question: Gross margin expectations for segments - Management expects gross profit margins to improve throughout the year, driven by scale and process optimization [74][75]

Omeros (NasdaqGM:OMER) Q4 2025 Earnings call March 31, 2026 04:30 PM ET Company ParticipantsBrandon Folkes - Managing DirectorDavid Borges - Chief Accounting OfficerGreg Demopulos - Chairman and CEOJennifer Williams - PrincipalNadia Dac - Chief Commercial OfficerSerge Belanger - Managing Director of BioPharma Equity ResearchSteve Brozak - President and Managing PartnerConference Call ParticipantsSam Rodriguez - Biotech Equity Research AnalystOperatorPlease be advised that this call is being recorded at the ...

Omeros (NasdaqGM:OMER) Q4 2025 Earnings call March 31, 2026 04:30 PM ET Company ParticipantsBrandon Folkes - Managing DirectorDavid Borges - Chief Accounting OfficerGreg Demopulos - Chairman and CEOJennifer Williams - PrincipalNadia Dac - Chief Commercial OfficerSteve Brozak - President and Managing PartnerConference Call ParticipantsSam Rodriguez - Biotech Equity Research AnalystSerge Bellinger - Equity Research Analyst of BiotechnologyOperatorPlease be advised that this call is being recorded at the compa ...

MDB Capital Holdings (NasdaqCM:MDBH) Q4 2025 Earnings call March 31, 2026 04:30 PM ET Company ParticipantsChristopher Marlett - CEO and Co-FounderGeorge Brandon - President and Head of Community DevelopmentOperatoreveryone to the MDB Capital Holdings fourth quarter and full year 2025 update conference call. Thanks very much for joining us today. At this time, all participants are in the listen-only mode. Before we begin the formal presentation, I'd like to remind everyone of several important things. Today' ...

Ed Woo - Director of Research and Senior Analyst Operator Good afternoon. Welcome to Duos Technologies' fourth quarter and full year 2025 earnings conference call. Joining us for today's call are Duos President, Doug Recker, and CFO, Leah Brown. Following the remarks, we will open the call to your questions. Before we conclude today's call, I'll provide the necessary cautions regarding the forward-looking statements made by management during this call. Now, I'd like to turn the call over to Mr. Doug Recker. ...